Subcutaneous allergen immunotherapy for asthma: A randomized, double-blind, placebo-controlled study with a standardized Blomia tropicalis vaccine

Subcutaneous allergen immunotherapy for asthma: A randomized, double-blind, placebo-controlled study with a standardized Blomia tropicalis vaccine

Background: Sensitization to Blomia tropicalis (Bt) is very frequent in the tropics, and particularly in Cuba, being a significant cause of allergic asthma. Allergen immunotherapy (AIT) with Bt can be a therapeutic option, however, placebo-controlled clinical trials have not been reported. Objective...

Full description

Bibliographic Details
Main Authors: Raúl Lázaro Castro-Almarales, Mercedes Ronquillo-Díaz, Mirta Álvarez-Castelló, José Rodríguez-Canosa, Mayda González-León, Irene Enríquez-Domínguez, Bárbara Ivonne Navarro-Viltre, Maytee Mateo-Morejón, Yunia Oliva-Díaz, Wendy Ramírez-González, Linda Cox, Alexis Labrada-Rosado
Format: Article
Language:English
Published: Elsevier 2020-04-01
Series:World Allergy Organization Journal
Subjects:
Subcutaneous immunotherapy
Blomia tropicalis
Standardized allergen extract
Clinical trial
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455120300016

Internet

http://www.sciencedirect.com/science/article/pii/S1939455120300016

Similar Items